Signalife awarded new U.S. electrocardiography related patent

Signalife, Inc. has announced that The United States Patent and Trademark Office has awarded to the company patent #7,299,083 entitled "Electrode For, And Method Of, Indicating Signal Characteristics At Particular Positions In A Patient's Body".

This patent, which covers 56 patent claims, is one of several patents filed by Signalife over the last five years.

Dr. Budimir S. Drakulic, Signalife's Chief Technology Officer, stated: "At the company's inception we carefully assessed the field of electrocardiography and electrocardiographic devices. Each aspect of electrocardiographic monitoring was scrutinized.

Based on the knowledge gained during this assessment process, we developed a solution for ultimate electrocardiographic devices. Patent applications were filed for patents only upon the complete verification of the underlying scientific principles.

I am very proud of our research and development team, which has developed a very significant patent portfolio. Under the leadership of Dr. Lowell Harmison, our new CEO, we are now making an important impact in the cardiac market".

http://www.signalife.com/